Ladenburg Thalmann Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$693K Buy
70,813
+5,579
+9% +$54.6K ﹤0.01% 1553
2019
Q3
$449K Sell
65,234
-13,443
-17% -$92.5K ﹤0.01% 1848
2019
Q2
$726K Sell
78,677
-9,405
-11% -$86.8K 0.01% 1452
2019
Q1
$1.38M Sell
88,082
-1,646
-2% -$25.8K 0.01% 973
2018
Q4
$1.39M Sell
89,728
-11,609
-11% -$180K 0.01% 860
2018
Q3
$2.18M Buy
101,337
+27,631
+37% +$595K 0.02% 684
2018
Q2
$1.26M Hold
73,706
0.01% 929
2018
Q1
$1.26M Sell
73,706
-10,068
-12% -$172K 0.01% 929
2017
Q4
$1.59M Buy
83,774
+7,694
+10% +$146K 0.02% 807
2017
Q3
$1.35M Sell
76,080
-4,471
-6% -$79.5K 0.01% 819
2017
Q2
$2.68M Buy
80,551
+4,543
+6% +$151K 0.03% 480
2017
Q1
$2.44M Buy
76,008
+25,634
+51% +$824K 0.03% 493
2016
Q4
$1.85M Buy
50,374
+15,304
+44% +$561K 0.03% 545
2016
Q3
$1.61M Buy
35,070
+2,731
+8% +$126K 0.02% 573
2016
Q2
$1.62M Buy
32,339
+4,016
+14% +$202K 0.03% 548
2016
Q1
$1.52M Sell
28,323
-2,438
-8% -$131K 0.03% 522
2015
Q4
$2.02M Buy
30,761
+1,674
+6% +$110K 0.04% 412
2015
Q3
$1.65M Sell
29,087
-8,415
-22% -$476K 0.03% 447
2015
Q2
$2.22M Sell
37,502
-1,367
-4% -$80.9K 0.04% 397
2015
Q1
$2.43M Buy
38,869
+11,330
+41% +$707K 0.05% 372
2014
Q4
$1.58M Sell
27,539
-166
-0.6% -$9.55K 0.04% 425
2014
Q3
$1.49M Sell
27,705
-3,975
-13% -$214K 0.04% 376
2014
Q2
$1.66M Sell
31,680
-32
-0.1% -$1.68K 0.05% 342
2014
Q1
$1.68M Buy
31,712
+8,019
+34% +$424K 0.05% 304
2013
Q4
$950K Buy
23,693
+6,008
+34% +$241K 0.03% 459
2013
Q3
$668K Sell
17,685
-1,964
-10% -$74.2K 0.02% 553
2013
Q2
$770K Buy
+19,649
New +$770K 0.03% 481